Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group (Q46208434)

20 December 2017

title

Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group (English)

1 reference

20 December 2017

6

Plotkin SA

1 reference

20 December 2017

author name string

Blumberg DA

1

1 reference

20 December 2017

Mink CM

2

1 reference

20 December 2017

Cherry JD

3

1 reference

20 December 2017

Johnson C

4

1 reference

20 December 2017

Garber R

5

1 reference

20 December 2017

Watson B

7

1 reference

20 December 2017

Ballanco GA

8

1 reference

20 December 2017

Daum RS

9

1 reference

20 December 2017

Sullivan B

10

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 August 1991

1 reference

20 December 2017

The Journal of Pediatrics

published in

1 reference

20 December 2017

volume

119

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

194-204

1 reference

20 December 2017

Developments in pertussis immunisation in Japan

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Analysis of Categorical Data by Linear Models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Analyses of adverse reactions to diphtheria and tetanus toxoids and pertussis vaccine by vaccine lot, endotoxin content, pertussis vaccine potency and percentage of mouse weight gain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Neutralizing antibodies to pertussis toxin in whooping cough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

Natural history of pertussis antibody in the infant and effect on vaccine response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980727-9

10.1016/S0022-3476(05)80727-9

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017